CN101027004A - Systems and methods for treating ischemic stroke - Google Patents
Systems and methods for treating ischemic stroke Download PDFInfo
- Publication number
- CN101027004A CN101027004A CN 200580029886 CN200580029886A CN101027004A CN 101027004 A CN101027004 A CN 101027004A CN 200580029886 CN200580029886 CN 200580029886 CN 200580029886 A CN200580029886 A CN 200580029886A CN 101027004 A CN101027004 A CN 101027004A
- Authority
- CN
- China
- Prior art keywords
- receptor
- thromboembolic material
- main body
- separator element
- conduit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Surgical Instruments (AREA)
Abstract
Description
技术领域technical field
本发明大致涉及医学治疗领域,并且更具体涉及一种用于治疗缺血性中风(ischemic stroke)的系统及方法,其包括从患者的脑动脉去除血栓栓塞。The present invention relates generally to the field of medical therapy, and more particularly to a system and method for treating ischemic stroke, including removal of a thromboembolism from a cerebral artery of a patient.
背景技术Background technique
中风是死亡以及残废的首要原因,也是不断增长的全球性卫生保健问题。单在美国,每年就有超过700,000人经受大中风的痛苦,并且其中超过150,000人死亡。更加困扰的是,预期这种已经很麻烦的情况随着“生育高峰”人口到达老龄而变得更糟,特别是那些经受不良饮食、肥胖和/或其他导致中风的起作用因素的人。在中风幸存者中,大约90%的人在行动、感观、记忆或者思维上受到长期的中度到重度损伤。US卫生保健系统的总费用为每年超过$500亿。Stroke is the leading cause of death and disability and a growing global health care problem. In the United States alone, more than 700,000 people suffer from a major stroke each year, and more than 150,000 of them die. Even more troubling, this already troubling condition is expected to get worse as the "baby boomer" population ages, especially those who suffer from poor diet, obesity and/or other contributing factors to stroke. Among stroke survivors, approximately 90 percent suffer long-term moderate to severe impairment in movement, senses, memory or thinking. The total cost of the US health care system is over $50 billion per year.
中风可以由脑动脉破裂(“出血性中风”)或者由于血栓栓塞产生的脑动脉阻塞(“缺血性中风”)引起。血栓栓塞是经血流行进并沉淀由此阻碍或者阻塞血管的分离血液凝块。在这两种中风之间,缺血性中风包括更大的问题,美国每年超过600,000人经受缺血性中风。Strokes can be caused by rupture of a cerebral artery ("hemorrhagic stroke") or blockage of a cerebral artery due to thromboembolism ("ischemic stroke"). Thromboembolism is a detached blood clot that travels through the bloodstream and settles thereby obstructing or blocking a blood vessel. Between these two types of stroke, ischemic stroke comprises the larger problem, with more than 600,000 people in the United States experiencing ischemic stroke each year.
缺血性中风治疗可以通过血栓栓塞的药理学消除和/或血栓栓塞的机械消除完成。药理学消除可以通过注射设计为溶解或者防止血栓栓塞进一步生长的溶解血栓剂完成(例如,溶栓酶、尿激酶、组织血浆酶原催化剂(TPA))和/或抗凝血药物(例如,肝磷脂、杀鼠灵(warfarin))。药理学治疗是非介入性的并且通常对溶解血栓栓塞有效。尽管有这些通常有利的方面,但是使用药理学治疗存在明显的缺陷。一种缺陷是溶解血栓剂和/或抗凝血剂见效以及恢复血流所需的时间量相对较大。由于治疗缺血性中风的时间紧迫性,任何附加时间都是潜在地破坏性的。另一明显缺陷是提高了由溶解血栓剂和/或抗凝血剂导致的体内其他位置流血或者出血的可能。Treatment of ischemic stroke can be accomplished by pharmacological ablation of thromboembolism and/or mechanical ablation of thromboembolism. Pharmacological elimination can be accomplished by injection of thrombolytic agents (eg, thrombolytic enzymes, urokinase, tissue plasminogen catalyst (TPA)) and/or anticoagulant drugs (eg, liver Phospholipids, warfarin). Pharmacological treatments are non-invasive and are usually effective in dissolving thromboembolism. Despite these generally favorable aspects, there are significant drawbacks to the use of pharmacological treatments. One drawback is the relatively large amount of time required for thrombolytic and/or anticoagulant agents to take effect and restore blood flow. Due to the time urgency of treating ischemic stroke, any additional time is potentially devastating. Another significant drawback is the increased likelihood of bleeding or hemorrhage elsewhere in the body caused by thrombolytic and/or anticoagulant agents.
已经尝试使用各种基于导管的经腔血管的介入技术的治疗缺血性中风的血栓栓塞材料的机械消除。一种介入技术包括将线圈(coil)展开到血栓栓塞(例如,通过螺旋作用)以便俘获或者包围血栓栓塞使其能够从患者去除。尽管对缺血性中风的药理治疗进行了改进,但由于血栓栓塞材料滑脱或者被线圈驱散,这种基于线圈的收回系统在克服缺血性中风上仅取得了部分成功(大约55%)。在后一情况下,血栓栓塞材料的驱散可能在同一动脉或连接动脉内导致另外的中风。Mechanical ablation of thromboembolic material in the treatment of ischemic stroke has been attempted using various catheter-based transluminal vascular interventional techniques. One interventional technique involves deploying a coil to the thromboembolism (eg, by helical action) in order to capture or surround the thromboembolism so that it can be removed from the patient. Despite improvements in the pharmacological treatment of ischemic stroke, such coil-based retrieval systems have only been partially successful (approximately 55%) in overcoming ischemic stroke due to thromboembolic material slipping off or being dissipated by the coil. In the latter case, dissipation of the thromboembolic material may result in additional strokes within the same artery or connecting arteries.
另一种介入技术包括从血栓栓塞向远端(或者下游)展开篮或者网结构,以便俘获或者包围血栓栓塞使其能够从患者去除。同样,尽管克服了药理学治疗的缺陷,但其明显缺陷在于在没有脉管系统的血管造影路标(angiographic roadmap)可视化的情况下从阻塞段向远端操纵篮或网结构的动作增加了损坏血管的风险。此外,不然的话,取出篮或网结构可能使血栓栓塞材料进入连接的动脉。如上文提到的,这将在连接动脉中导致另外的中风。Another interventional technique involves deploying a basket or mesh structure distally (or downstream) from the thromboembolism in order to capture or surround the thromboembolism so that it can be removed from the patient. Also, while overcoming the drawbacks of pharmacological therapy, its apparent drawback is that manipulation of the basket or mesh structure distally from the obstructed segment without visualization of the angiographic roadmap of the vasculature increases the risk of damaging the vessel . Furthermore, removal of the basket or mesh structure may otherwise allow thromboembolic material to enter the attached artery. As mentioned above, this will cause an additional stroke in the connecting artery.
治疗缺血性中风的再一种介入技术包括将吸管推进到血栓栓塞,以便通过吸取(即,负压力)将其去除。尽管通常是安全的,但是通过吸取去除仅对相对软的血栓栓塞有效。为了加强吸取技术的效果,已经采用旋转刀片切断或者击碎血栓栓塞,随后通过吸管去除。尽管这种旋转刀片零件改进了这种吸取技术的效果,但是增加了由于旋转刀片引起的损坏血管的风险。Yet another interventional technique for the treatment of ischemic stroke involves advancing a straw into the thrombus to remove it by suction (ie, negative pressure). Although generally safe, removal by suction is only effective for relatively soft thromboemboli. To enhance the effect of the suction technique, a rotating blade has been used to cut or break up the thromboembolism, which is subsequently removed through a suction tube. Although this rotating blade part improves the effect of this suction technique, it increases the risk of damage to the vessel due to the rotating blade.
上述介入技术,以及现有技术中的其他技术,全都具有一个或多个缺陷并且被认识对于治疗缺血性中风是次最佳的。本发明针对于克服或者至少改进现有技术的缺点。The interventional techniques described above, as well as others in the prior art, all suffer from one or more deficiencies and are recognized as suboptimal for treating ischemic stroke. The present invention aims at overcoming or at least improving the disadvantages of the prior art.
附图说明Description of drawings
通过结合所附附图阅读本说明书,本发明的许多优点对于本领域技术人员显而易见,其中相同的附图标记用于相同的元件,并且其中:The many advantages of the present invention will become apparent to those skilled in the art from a reading of this specification in conjunction with the accompanying drawings, in which like reference numerals are used for like elements, and in which:
图1是血栓栓塞去除系统一实施例的部分截面侧视图,包括导引及阻塞导管、输送及吸取导管、吸取泵、血栓栓塞接收器以及血栓栓塞分离器;1 is a partial cross-sectional side view of one embodiment of a thromboembolic removal system, including guide and occlusion catheters, delivery and aspiration catheters, an aspiration pump, a thromboembolic receiver, and a thromboembolic separator;
图2是形成图1所示血栓栓塞去除系统的部件的输送及吸取导管的部分截面侧视图,显示了处于未展开状态的血栓栓塞接收器元件;Fig. 2 is a partial cross-sectional side view of a delivery and aspiration catheter forming part of the thromboembolic removal system shown in Fig. 1, showing the thromboembolic receiver element in an undeployed state;
图3是图1所示血栓栓塞去除系统的部件的输送及吸取导管的部分截面侧视图,显示了处于展开状态的血栓栓塞接收器元件;3 is a partial cross-sectional side view of the delivery and aspiration catheter of the components of the thromboembolic removal system shown in FIG. 1, showing the thromboembolic receiver element in an expanded state;
图4A是描述装配有多个啮合元件的血栓栓塞接收器的备选实施例的透视图;Figure 4A is a perspective view illustrating an alternative embodiment of a thromboembolic receiver equipped with multiple engagement elements;
图4B是沿图4A的标记为4B-4B的平面的截面视图;Figure 4B is a cross-sectional view along the plane labeled 4B-4B of Figure 4A;
图4C是显示图4A的血栓栓塞接收器的远端部分的透视图;Figure 4C is a perspective view showing the distal portion of the thromboembolic receiver of Figure 4A;
图5是图4的备选血栓栓塞接收器的平面图,尽管接收器优选是管状结构,但图5将其显示成打开并展平成片状以便更容易地观察其特征;Figure 5 is a plan view of the alternative thromboembolic receiver of Figure 4, although the receiver is preferably a tubular structure, Figure 5 shows it opened and flattened into a sheet for easier viewing of its features;
图6是显示用于将血栓栓塞接收器(例如图4A的接收器)挠性耦接到延长构件或输送及吸取导管的挠性区域一实施例的顶部视图;6 is a top view showing an embodiment of a flexible region for flexibly coupling a thromboembolic receiver, such as the receiver of FIG. 4A , to an elongate member or delivery and aspiration catheter;
图7是装配有在血栓栓塞接收器展开之后能够选择性展开的多个啮合元件的备选血栓栓塞接收器的透视图;7 is a perspective view of an alternative thromboembolic receiver equipped with a plurality of engagement elements that are selectively deployable after deployment of the thromboembolic receiver;
图8A是具有用于促进接收器重新加载到导管内的零件的血栓栓塞接收器的透视图;Figure 8A is a perspective view of a thromboembolic receiver with features to facilitate reloading of the receiver into the catheter;
图8B是与图5的视图类似的显示图8A的血栓栓塞接收器的平面图;8B is a plan view similar to the view of FIG. 5 showing the thromboembolic receiver of FIG. 8A;
图8C是图8A的血栓栓塞接收器的近端部分以及耦接到血栓栓塞接收器的延长构件的远端部分的透视图,显示了血栓栓塞接收器回缩到输送及吸取导管内;8C is a perspective view of the proximal portion of the thromboembolic receiver of FIG. 8A and the distal portion of the elongate member coupled to the thromboembolic receiver, showing retraction of the thromboembolic receiver into the delivery and aspiration catheter;
图9和图10是与输送及吸取导管一同使用的血栓栓塞剥离器或分离器的一实施例的部分截面侧视图;9 and 10 are partial cross-sectional side views of one embodiment of a thromboembolic stripper or separator for use with delivery and aspiration catheters;
图11A是形成图9和图10所示的血栓栓塞分离器的部件的分离器元件的放大视图;11A is an enlarged view of a separator element forming part of the thromboembolic separator shown in FIGS. 9 and 10;
图11B是血栓栓塞分离器的备选实施例的侧面主视图;Figure 1 IB is a side elevational view of an alternative embodiment of a thromboembolism separator;
图11C是形成图11B所示的血栓栓塞分离器的部件的分离器元件的放大视图;11C is an enlarged view of a separator element forming part of the thromboembolic separator shown in FIG. 11B;
图11D是与图11C类似的显示血栓栓塞分离器另一个备选实施例的侧面主视图;11D is a side elevational view similar to FIG. 11C showing another alternative embodiment of a thromboembolism separator;
图12是显示用于动脉系统中的图1的血栓栓塞去除系统的患者的部分截面视图;12 is a partial cross-sectional view of a patient showing the thromboembolism removal system of FIG. 1 used in an arterial system;
图13是显示用于脑动脉中的图1的血栓栓塞去除系统的远端区域的患者的部分截面视图;13 is a partial cross-sectional view of a patient showing the distal region of the thromboembolism removal system of FIG. 1 used in a cerebral artery;
图14是显示导引线向血栓栓塞推进的部分截面侧视图;Figure 14 is a partial cross-sectional side view showing advancement of a guide wire toward a thromboembolism;
图15是显示导引及阻塞导管推进同时气囊处于放气状态的部分截面侧视图;Figure 15 is a partial cross-sectional side view showing the advancement of the guide and occlusion catheter while the balloon is deflated;
图16是显示气囊阻塞构件充气以便抑制包含血栓栓塞的动脉内的血流的部分截面侧视图;16 is a side view, partially in section, showing inflation of a balloon occluding member to inhibit blood flow in an artery containing a thromboembolism;
图17是显示根据用于使用图1的系统的方法将图1-图3的输送及吸取导管推进到接近血栓栓塞的点的部分截面侧视图;17 is a partial cross-sectional side view showing the delivery and aspiration catheter of FIGS. 1-3 being advanced to the point of a thromboembolism according to the method for using the system of FIG. 1;
图18是显示图1-图3的血栓栓塞接收器展开的部分截面侧视图;Fig. 18 is a partial cross-sectional side view showing the thromboembolic receiver of Figs. 1-3 deployed;
图19是显示图1-图3的输送及吸取导管向远端推进以使图1-图3的血栓栓塞接收器(全部或部分)啮合血栓栓塞的部分截面侧视图;19 is a partial cross-sectional side view showing the delivery and aspiration catheter of FIGS. 1-3 advanced distally to engage the thromboembolic receiver (in whole or in part) of FIGS. 1-3;
图20以及图21显示了图1-图3的血栓栓塞接收器移动到导引及阻塞导管内以便去除血栓栓塞的部分截面侧视图;20 and 21 show partial cross-sectional side views of the thromboembolic receiver of FIGS. 1-3 moved into the guide and occlusion catheter for removal of the thromboembolism;
图22是显示使用图1以及图9-图11C的血栓栓塞分离器来啮合血栓栓塞的远端部的部分截面侧视图;22 is a partial cross-sectional side view showing the use of the thromboembolic separator of FIGS. 1 and 9-11C to engage the distal portion of a thromboembolism;
图23是显示使用图1以及图9-图11C的血栓栓塞分离器来分裂和/或软化血栓栓塞并且/或者辅助吸取的部分截面侧视图;23 is a partial cross-sectional side view showing the use of the thromboembolism separator of FIGS. 1 and 9-11C to disrupt and/or soften a thromboembolism and/or assist in suction;
图24是显示独立使用图1以及图9-图11C的血栓栓塞分离器来分裂和/或软化血栓栓塞并且/或者辅助吸取的部分截面视图;24 is a partial cross-sectional view showing the use of the thromboembolism separator of FIGS. 1 and 9-11C alone to disrupt and/or soften a thromboembolism and/or to assist suction;
图25以及图26显示图4-图6的血栓栓塞接收器向远端推进以使其包围血栓栓塞的部分截面视图;以及25 and 26 show partial cross-sectional views of the thromboembolic receiver of FIGS. 4-6 advanced distally so that it surrounds a thromboembolism; and
图27以及图28是显示图4-图6血栓栓塞接收器以及输送及吸取导管抽回到导引及阻塞导管内以便去除血栓栓塞的部分截面侧视图。27 and 28 are partial cross-sectional side views showing the withdrawal of the thromboembolic receiver and delivery and aspiration catheters of FIGS. 4-6 into the guide and occlusion catheters for removal of the thromboembolism.
具体实施方式Detailed ways
下面将描述本发明的示意性实施例。为了清晰起见,在本说明书中不描述实际实现方式的所有特征。当然要知道,在任何这样的实际实施例的开发中,必须作出许多特定应用的决定,以便实现开发者的特定目的,例如依从系统相关以及商业相关的限制,这根据实施方式而彼此不同。此外,要知道开发努力可能是复杂而且耗时的,但是受益于本公开内容的本领域技术人员的非创造性劳动。本申请所公开的血栓栓塞去除系统包含单独或者组合保证专利保护的各种发明性特征以及元件。Illustrative embodiments of the present invention will be described below. In the interest of clarity, not all features of an actual implementation are described in this specification. It will of course be appreciated that in the development of any such actual embodiment, many application-specific decisions must be made in order to achieve the developer's specific goals, such as compliance with system-related and business-related constraints, which vary from implementation to implementation. Furthermore, it is understood that a development effort could be complex and time consuming but was nonetheless the uninventive endeavor of those skilled in the art with the benefit of this disclosure. The thromboembolism removal system disclosed in this application contains various inventive features and elements that alone or in combination warrant patent protection.
系统特征system features
图1显示了血栓栓塞去除系统10的示范性实施例。该血栓栓塞去除系统10包括导引及阻塞导管12、输送及吸取导管14、血栓栓塞剥离器或分离器16以及吸取泵18。如下文更详细描述的,血栓栓塞去除系统10有利地提供了从患者体内的脑动脉去除血栓栓塞的能力,同时克服了现有技术的缺点及局限。FIG. 1 shows an exemplary embodiment of a
导引及阻塞导管12包括具有在近端部24和远端部26之间延伸的主管腔22的管状导管构件20。导管构件20可由具有适当生物适应性以及强度特征的许多成分构建而成,并且可以依据进入脉管系统之进入点、血栓栓塞的位置、患者解剖结构的差异以及任何减轻情况(extenuating circumstance),将其尺寸限定成许多适当的尺寸以及长度。在示范性实施例中,导管构件20可以由带有嵌入式不锈钢编织物的尼龙构成并且尺寸限定为具有从70cm到110cm的长度以及从5French(0.065英寸)到9French(0.117英寸)的直径。气囊阻塞构件28设置在远端部26或者附近。为了对阻塞构件28进行选择性充气,提供经设置于管状导管构件20的壁内的至少一管腔(未图示)与阻塞构件28流体连通的充气端口30。提供密封件32以便使输送及吸取导管14以无泄漏、止血方式通过导引及阻塞导管12的主管腔22。The guide and
输送及吸取导管14包括具有在远端部38和近端部40之间延伸的主管腔36的管状导管元件34。导管构件34可以由具有适当生物适应性和强度特征的许多成分构成并且可以依据进入脉管系统的进入点、血栓栓塞的位置、患者解剖结构的差异以及减轻情况尺寸限定成许多尺寸以及长度。在示范性实施例中,导管构件34可以由具有嵌入式不锈钢编织物的PEBAX构成并且尺寸限定为具有从130cm到170cm的长度以及从2.5French(0.032英寸)到5French(0.065英寸)的直径。Delivery and
输送及吸取导管14还包括耦接到近端部40的中枢组件42,以便将管腔36耦接到吸取泵18。中枢组件42还包括密封件44以便允许血栓栓塞分离器16(以及如下文所描述的展开接收器元件46的推动装置)以无泄漏、止血方式通过管腔36。管腔优选包覆有PTFE或者本领域公知的各种适当润滑材料的另外一种。Delivery and
如参照图2-图3所最佳观察到的,血栓栓塞接收器元件46能够在管腔36(图2)内保持成收回或未展开状态(图2)并且能够选择性从远端部38推出和/或拔出进入展开状态(图3)。血栓栓塞接收器46可以由具有适当生物适应性以及强度特征的许多成分构成,并且可以依据血栓栓塞的位置、患者解剖结构的差异以及血栓栓塞的尺寸和形状尺寸限定成许多适当的尺寸和形状。如图3和图5中所最佳观察到的,血栓栓塞接收器46由多个支柱构件47形成,其在展开后沿血栓栓塞接收器46的外围产生大量大致菱形开口49。根据一个实施例,如图18-图23所示,血栓栓塞接收器46的远端区域的结束点(resulting point)装配有钝尖零件51以便于血栓栓塞接收器46在没有阻碍或者以其他方式粘贴在通到脑动脉的动脉或者分支血管壁的情况下通过脑动脉。As best seen with reference to FIGS. 2-3 , the
在导管元件34内提供推动元件48以便用于将接收器元件46从管腔36内推进或者推动到完全或部分展开的状态。仅作为实例,推动元件48包括适当构造(例如,线或者绕线的)的延长构件50,其具有尺寸限定为接触形成接收器元件46的部件(或者耦接于其上的)近端终端54的远端邻接件52。尽管未图示,但要知道推动元件48可以包括许多用于推动接收器元件46进行展开的适当装置,包括但不局限于具有尺寸限定为接触接收器元件46的近端终端54的远端部的导管。在一实施例中,这种推进导管可以具有尺寸限定为接收和/或通过血栓栓塞分离器16的内设管腔。A
图4A显示了备选实施例的血栓栓塞接收器146。血栓栓塞接收器146可由具有适当生物适应性以及强度特征的多个成分构成,并且可以依据血栓栓塞的位置、患者解剖结构的差异以及血栓栓塞的尺寸和形状尺寸限定成许多适当的尺寸以及长度。在优选实施例中,血栓栓塞接收器146由具有“形状记忆”或者超弹性特性的镍钛诺构成。通过这种方式,血栓栓塞接收器146能够在展开之前保持成受限形式或者形状。接收器可以通过将零件激光切割成一定长度的镍钛诺管材,并且随后使用本领域普通技术人员公知的方法对材料进行一次或多次化学蚀刻以及形状设定形成。FIG. 4A shows a
参照图4A,接收器146安装到延长构件151上,延长构件151优选配设(proportion)成经输送及吸取导管14的管腔36(图1)延伸。支柱构件或者“支脚”162在接收器146和延长构件151之间延伸并且优选使用粘结、收缩管材或者其他公知方法附着到延长构件151上。在优选实施例中,构件151是延长的棒、导管、线或者其他延长构件。在本实施例中,配设血栓栓塞接收器146使其在输送及吸取导管14内(以图1-图3所示的方式类似的方式)限制在压缩位置。作为备选方案,延长构件151可以是输送及吸取导管14,在这种情况下接收器146以及输送及吸取导管14适于延伸通过导引及阻塞导管12。Referring to FIG. 4A ,
在任一情况下,血栓栓塞接收器146可以通过将血栓栓塞接收器146简单地推出将其限制在未展开状态的元件(例如,导引及阻塞导管12或者输送及吸取导管14)而自动展开-由于镍钛诺的形状记忆或超弹性特性。一旦展开,血栓栓塞接收器146可以用于接收血栓栓塞。优选选定接收器146的尺寸以便当其在体温下处于膨胀状态时,接收器的远端部分的外表面接触周围的血管壁。在适于大多数颅内血管的实施例中,接收器可以膨胀到大约2-6mm的最大外径,并且更优选为2-5mm。对于例如普通颈动脉内程序的其他应用,大约6-9mm范围内的最大外径是适当的。In either case, the
在不脱离本发明的范围的情况下,血栓栓塞接收器146可以形成为具有各种适当几何外形和特征。根据图4A和图5所示的一实施例,血栓栓塞接收器146由个支柱构件形成,其在展开后沿血栓栓塞接收器146的外围产生大量大致矩形的开口149(图5中最佳观察到的)。作为实例,这可以通过提供多个纵向支柱构件或者“立柱”150(大致平行于输送及吸取导管14的纵轴)以及多个横向支柱构件152(在相邻立柱之间大致垂直延伸)实现。在优选实施例中,支柱构件共同限定具有如图4B所示的中心腔147的大致柱状的远端部分。
横向支柱构件152可以包括许多弯曲或者波动,例如在横向支柱构件152和立柱150之间交点附近所示的弯曲153a以及图5所示的交点中间的弯曲153b。这些弯曲或波动有助于允许血栓栓塞接收器146折叠成压缩或受限状态,这是将血栓栓塞接收器146设置在输送及吸取导管14或导引及阻塞导管12内所需要的。
在优选实施例中,横向支柱构件152形成最靠近输送及吸取导管14的近端封套154、定位在血栓栓塞接收器146的远端或者开放端的远端封套156以及位于近端封套和远端封套之间某点的中间封套158。各封套(近端封套154、中间封套158以及远端封套156)为设计成增强血栓栓塞接收器146的结构支撑和稳定性以及有助于在展开后将血栓栓塞接收器146保持在所需形状的周向环(以便改善到血管壁的附着来优化血栓栓塞的回收)。In a preferred embodiment, the
由封套154-158所提供的结构支撑可以通过在一个或多个大致矩形开口149内提供一个或多个稳定支柱构件160而加强。根据一实施例,这些稳定支柱构件160可以采用从血栓栓塞接收器146内的给定大致矩形开口149的近端部或者远端部延伸的“V”形式。在优选实施例中,这种“V”形稳定支柱构件160提供在血栓栓塞接收器146内的大致矩形开口149的近端以及远端组内。这样有利地增加血栓栓塞接收器146的近端和远端区域的结构稳定性。无论其特定形状,稳定支柱构件160优选包括折叠区域或者顶点169,其允许它们在接收器压缩到收缩位置时在顶点169(参见图5中的箭头A)折叠。此外,接收器优选构建成允许支柱构件160在与形成接收器的其他元件相交的区域折叠,(例如在图5的实施例中,支柱构件160和立柱150之间的相交区域)。The structural support provided by the envelopes 154 - 158 may be enhanced by providing one or more stabilizing
尽管血栓栓塞接收器146的结构稳定性是所需目标,但还希望具有特定方面的挠性。根据一实施例,在血栓栓塞接收器146和延长构件151之间的接合点(或者输送及吸取导管14的远端部)提供相对挠性。仅作为实例,这通过提供多个在近端封套和延长构件151之间延伸的连接器支柱构件或“支脚”162(如图5中最佳观察的)以包括靠近延长构件151的远端部附近的的挠曲区域164实现。挠曲区域164可以形成为任何形状,只要该形状可在不包括沿支柱构件162的长度传递轴向作用力的用户能力的情况下增加支柱构件162的挠性。在图6所示的备选实施例中,挠曲区域164a可以包括位于连接器支柱162的近端部的多个蜿蜒的“S”形支柱166a。根据另一实施例,可以在相邻纵向支柱构件或立柱150之间的接合点提供挠曲区域或者弹簧区域168(图5)(其可以包括一个或多个“S”形弯曲或者设计为提供挠性同时保持足够的柱强度的形状)。在这两种实例中,这些挠曲区域164、168的优点在于它们允许血栓栓塞接收器146在不牺牲所需柱强度的情况下更好地跟踪并沿曲折的血管推进。While structural stability of the
根据另一实施例,血栓栓塞接收器146还可以包括各种零件以加强血栓栓塞接收器146和血栓栓塞之间的啮合。仅作为实例,这可以通过在血栓栓塞接收器上提供多个啮合元件170实现。如图4A、图4B以及图5中最佳观察到的,根据一实施例,啮合元件170可以采取耦接在血栓栓塞接收器146的远端部或者附近并在相邻立柱150之间延伸的“V”形结构。啮合元件优选成角度进入血栓栓塞接收器的管腔147(参见图4B和图4C)以便允许管腔内俘获的血栓栓塞的啮合。在不脱离本发明的范围的情况下可以采用许多啮合元件170。在一实施例,可以采用三个(3)分开的啮合元件170,各啮合元件设置为沿血栓栓塞接收器146的外围彼此成一百二十(120)度。在优选实施例中,啮合元件170采取图4A和图5所示的多个稳定支柱构件160的形式。According to another embodiment, the
当血栓栓塞接收器146展开(如图4-图5所示)时,啮合元件170可以自动展开。根据图7所示的本发明的另一方面,啮合元件170a还可以在血栓栓塞接收器146a展开后在任意点选择性展开。根据图7的实施例,通过将一个或多个延长元件172通过血栓栓塞接收器146a实现啮合元件170a的选择性展开以便防止啮合元件170a从中间延伸到血栓栓塞接收器146的管腔内。当需要展开时,用户仅需要在近端方向上(朝用户)拉动延长元件172,直到将啮合元件170a设定为独立于延长元件172的限制。当出现这种情况时,啮合元件170a的“形状记忆”或者超弹性属性使得它们呈现自然状态,从中间延伸到血栓栓塞接收器146a的管腔内。通过这种方式,啮合元件170a将啮合血栓栓塞并因而有助于或者增强血栓栓塞接收器146a去除血栓栓塞的能力。
血栓栓塞接收器可以设置有允许医生在接收器已经部分或全部展开在血管内后将接收器缩回到输送及吸取导管内的零件。这可能是必须的,如果医生接收到血管造影或触觉反馈,其指示出分离器是用于去除特定栓塞的优选工具或者不同尺寸的接收器更适于特定过程。The thromboembolic receiver may be provided with features that allow the physician to retract the receiver into the delivery and aspiration catheter after the receiver has been partially or fully deployed within the blood vessel. This may be necessary if the physician receives angiographic or tactile feedback indicating that a separator is the preferred tool for removing a particular embolism or that a different sized receiver is better suited for a particular procedure.
图8A显示了与图4的接收器146类似但包括便于将接收器重新加载到输送及吸取导管14内的零件的血栓栓塞接收器146b的实施例的一个实例。如图所示,图8A的实施例的接收器146b包括单个远端封套152b以及从封套152b向近端延伸的多个纵向支柱构件150b。FIG. 8A shows an example of an embodiment of a thromboembolic receiver 146b similar to
如图8B所示,结构支撑构件160b配置在与封套152b相邻的远端列171a以及更近端列171b中。与图4实施例一样,远端列内的多个结构支撑构件160b向内偏置到接收器146b的中心腔147b内以便作为用于啮合血栓栓塞的啮合构件170b。As shown in FIG. 8B, the
三种类型的稳定支柱构件朝接收器146b的近端部延伸。第一种,支柱构件162b从远端列171a的结构支撑构件160b中那些不作为啮合构件的支撑构件的顶点向远端延伸。这些支柱构件162b在中间点耦接到近端列171b中的纵向对齐的支撑构件160b的顶点。第二种,支柱构件162c形成纵向支柱构件150b的近端外延并且在其近端部包括眼孔163。第三种,支柱构件162d从近端列的结构支撑构件160b中那些与啮合构件170b纵向对齐的支撑构件的顶点延伸。通过将某些或者所有支柱构件构建为包括结合前面的实施例描述的类型的挠曲区域(例如参见图5的挠曲区域168)增加了接收器146b的挠性。Three types of stabilizing strut members extend toward the proximal end of receiver 146b. First, strut
参照图8C,接收器146b包括推动器或者延长构件151b,其在其远端部包括管腔165。在接收器146b的组装过程中,如图所示,支柱构件162b、162d的近端部定位在管腔165中,并且允许在管腔165内自由滑动。使用热收缩管材167或者其他适当材料将支柱构件162c的近端部结合到延长构件151b的外表面。眼孔163通过允许结合材料流入眼孔的开口由此使各支柱构件162c的更大部分外露于结合材料而便于结合。如果需要,支柱构件162b和162d可以稍大于接收器的近端部处的支柱构件162c,以便在组装过程允许容易地对它们进行识别以插入管腔165。Referring to Figure 8C, the receiver 146b includes a pusher or
如果必需将接收器146b从完全或部分展开状态收回到输送及吸取导管14内,如图8C所示,在近端方向上相对导管抽回延长构件151b。随着接收器146b移入导管14,接收器在结构支撑构件160b的顶点开始折叠,由此在近端方向上推动支柱构件162b、162d。由于特定的结构支撑构件160b在其顶点由支柱构件162b互连的事实,比利用图4的接收器146更容易实现折叠。因而,近端列171b中的一个构件160b的折叠将促进远端列171a中相应构件160b的折叠。允许支柱构件162b、162d在延长构件151b的管腔165内自由滑动,以使它们在接收器146b抽回到导管14的过程中不抵抗构件160b的折叠。If it is necessary to retract receptacle 146b from a fully or partially deployed state into delivery and
图9中显示了血栓栓塞分离器的第一实施例。第一实施例的血栓栓塞分离器16包括具有近端部58和远端部60的延长元件56。延长元件56可由具有适当生物适应性以及强度特征的许多成分构建而成,并且可以依据进入脉管系统的进入点、血栓栓塞的位置、患者解剖结构的差异以及任何减轻情况尺寸限定成许多适当的尺寸以及长度。在示范性实施例中,延长元件56可由不锈钢和/或镍钛诺构成并且尺寸限定为具有150cm到200cm之间的长度以及从0.010英寸到0.021英寸的直径。润滑表面(例如,PTEE覆层、亲水性覆层或者其他适当覆层)可以涂覆到延长元件56的全部或者部分以便于元件在输送/吸取导管14的管腔内和/或脉管系统内的移动。A first embodiment of a thromboembolic separator is shown in FIG. 9 . The
如果需要,延长元件56可以采取在各种脉管应用中使用的类型的导引线形式。因而,延长元件可以任选地包括具有足以在导引线的推进过程中防止对脉管组织的损伤的挠性的线圈式远端部分57(图11B)。在示范性实施例中,线圈式远端部分57具有在大约27-33cm之间的长度。线圈优选定位在线圈式导引线中经常发现的类型的内心轴或者芯(未图示)周围。If desired,
分离器16的“工作端”包括附着或形成延长元件56的远端部60的部件的大致钝尖元件62以及附着或形成延长元件56的部件的分离器元件64。尖端元件62的尺寸优选限定为通过或靠着(against)血栓栓塞以便软化或者击碎血栓栓塞以进行去除。尖端元件62的钝属性有利地防止损伤,以便其不会在使用过程中引起脉管系统的内部的损坏。分离器16还有助于去除可能由于吸取过程中血栓栓塞材料经其通过而在管腔36内形成的阻塞或者流动限制。The "working end" of the
在一实施例中,如图11A最佳显示的,分离器元件64可以采取形状上大致为圆锥形的具有沿延长元件56面向近端的开口66的篮。分离篮64尺寸限定为有助于血栓栓塞击碎过程,以及接收这种血栓栓塞碎片以便有助于它们的去除。在一实施例中,分离篮64设置为具有网68以及一个或多个支撑构件70。支撑构件70的尺寸限定将网68偏置到所示的大致开放位置,并且如果需要则允许网68随着分离器16通过输送及吸取导管14、上文所描述的导管型推动器和/或血栓栓塞本身而呈现大致封闭的位置(未图示但是大致相对延长元件56平齐)。In one embodiment, as best shown in FIG. 11A , the
图11B以及图11C中显示了分离器16a的备选实施例,其中相同的附图标记用于识别与图9、图10以及图11A所示的零件相似的零件。分离器16a主要在分离器元件64a的零件与图9、图10以及图11A的分离器16有区别。参照图11B,分离器元件64a为由聚合物材料形成的圆锥构件,例如聚亚安酯或者Pebax聚醚嵌块氨化物。分离器元件64a优选是实心构件,表面65面向近端方向的,并且元件的锥形定向在远端方向上。表面65的轮廓可以多种方式限定。例如,表面65可以是如图11B所示的略微凹面、如图11C所示的基本平面或者如图11D所示的略微凸面。An alternative embodiment of a
分离器元件64a定位在延长元件56的线圈式远端部分57。线圈式部分57的一部分内的节距在线圈式远端部分57的特定区域内增加。以这种方式开放线圈内的间隔可以便于在成型过程中分离器元件的聚合物材料与线圈材料之间的粘合。分离器元件64a和延长元件56的远端部60之间的间距优选长到允许延长元件的最远端部分具有足以经脉管系统自动移动的挠性,但是短到防止在延长元件56的推进过程中最远端部分的折叠。在示范性实施例中,分离器元件64a的远端部可以定位成距远端部60大约3-9mm。应该注意到,延长元件56的线圈式部分57内的心轴或芯(未图示)可以具有选定为增强线圈式部分的挠性的渐缩直径。The
在分离器的近端部58提供手柄构件72(图9)以便向用户提供推进和/或操纵防损伤尖端元件62以及分离器64/64a的控制点(purchase point)。在一个实施例中,手柄构件72可以任何适当方式耦接到延长元件56,包括但不局限于提供设置在延长元件56内以便将这两个元件耦接到一起的大致刚性的外延(未图示)。通过使用许多粘合或熔合技术加强或者增强这种耦接。A handle member 72 (FIG. 9) is provided at the proximal end portion 58 of the separator to provide the user with a purchase point for advancing and/or manipulating the
在不脱离本发明的范围的情况下,可以以各种不同的配置提供分离器16。例如,除了上文描述的“自展开”实施例,图11A的分离篮64可以选择性展开,例如通过为分离篮64装配选择性将支撑构件70从大致相对延长元件56平齐放置的初始位置偏置或打开到大致径向膨胀的位置(图11A中的箭头所示)的机构。
应该知道,导引及阻塞导管12、输送及吸取导管14、血栓栓塞分离器16和/或血栓栓塞接收器46可以设置许多零件以便于在引入以及使用过程中这些元件的可视化,包括但不局限于具有装配辐射不透明标记以便改善射线照相成像的远端区域。It should be appreciated that the introducer and
如前面结合图1所讨论的,可以提供本申请描述的各种元件作为用于去除血栓栓塞材料的系统10的部件。血栓栓塞去除系统10可以包括导引及阻塞导管12、输送及吸取导管14、血栓栓塞分离器16/16a,血栓栓塞接收器(例如接收器46或者146)和吸取泵18,以及导引线和/或其他适于该程序的工具。在一个实施例,可以提供多个接收器46/146允许医生在程序期间顺序收回若干血栓栓塞。为了简单,各分开的接收器可以设置有分开的输送及吸取导管。系统10可以附加装配有用于阐述本申请所描述的各种用法的使用说明或其等同物。As previously discussed in connection with FIG. 1 , various elements described herein may be provided as components of
系统使用system use
现在将参照图12-图28描述使用血栓栓塞去除系统10的方法。如图12-图13所大致显示的,在第一示范性方法中,血栓栓塞去除系统10引入到患者的脉管系统,例如通过Seldinger技术。图14显示了该过程的第一步,该步骤包括将导引线104推进到接近血栓栓塞100的点。导引线104可以包括许多商业可购得的导引线,其操作是本领域众所周知的。然而,在一种方法中,分离器16的延长构件56(图11B)作为导引线104。A method of using the
图15显示了第二步,其包括在导引线104上方将导引及阻塞导管12推进到接近血栓栓塞的点。图16所示的下一步优选包括对气囊阻塞构件28进行充气,以便抑制包含血栓栓塞100的脑动脉102内的血流。如图17所示,随后经导引及阻塞导管12推进输送及吸取导管14以使输送及吸取导管14的远端部38定位在接近血栓栓塞100的点。在经导引及阻塞导管12延伸的导引线104和/或交换长度(exchange-length)的导引线(未图示但本领域众所周知)上方推进输送及吸取导管14可以促进这种情况。Figure 15 shows a second step which involves advancing the guide and
如图18所示,在该点,血栓栓塞接收器46从输送及吸取导管14的远端部38展开。在一个实施例,气囊阻塞28在该点进行充气(与如图16所示的在推进输送及吸取导管14之前进行充气相反)。随后。向远端推进输送及吸取导管14-如图19所示-使得血栓栓塞接收器46啮合和/或(部分或者全部)包围血栓栓塞100。在该点,如图20和图21所示,输送及吸取导管14可以抽回到导引及阻塞导管12内以便从患者16去除血栓栓塞12。At this point, the
为了加强去除血栓栓塞100的能力,或者在血栓栓塞接收器46初始不啮合血栓栓塞100的情况下,可以激活吸取泵18以便在输送及吸取导管14内建立负压力。通过这种方式,负压力产生在脑动脉102内并施加到血栓栓塞100。如上文提到的,可以在该过程中采用分离器16(或者图11B-图11D的分离器16a)(例如对其进行推进以及缩回到输送及吸取导管14的管腔36内)以便去除由于血栓栓塞材料经管腔36通过而产生的任何阻塞或者流动限制。负压力用于将血栓栓塞100(部分或全部)吸入血栓栓塞接收器46内。随后,可以将输送及吸取导管14抽回到导引及阻塞导管12内以便从患者去除血栓栓塞100。To enhance the ability to remove the
为了进一步加强去除血栓栓塞100的能力或者在吸取泵18不足以将所有或大部分血栓栓塞100吸入接收器46的情况下,可以将血栓栓塞分离器16/16a推进成与血栓栓塞的一部分接触或者如图22所示全部通过血栓栓塞100,并且用它来偏置或者啮合血栓栓塞100的远端部。这将增加与血栓栓塞100啮合的表面面积,这样将有利地允许其抽回到导引及阻塞导管12内,例如通过将分离器16/16a以及输送及吸取导管14同时抽回到导引及阻塞导管12内。To further enhance the ability to remove the
如图23所示,分离器16/16a还可以选择性经血栓栓塞100推进以及收回(或保持在接收器46外面)。这将用于打碎或者以其他方式软化血栓栓塞100。推进或者收回分离器16/16a还将用于去除在吸取过程中由于血栓栓塞材料通过输送及吸取导管14的管腔36产生的阻塞或者流动限制。在任一情况下,吸取泵18将血栓栓塞碎片106或者软化的血栓栓塞100吸入或者偏置到血栓栓塞接收器46和/或导管14内。随后,抽回输送及吸取导管14以便将血栓栓塞接收器46吸入到导引及阻塞导管12内以便从患者去除血栓栓塞100。As shown in FIG. 23, the
分离器元件64经血栓栓塞的选择性推进以及分离器元件收回到输送及吸取导管14内,优选结合吸取,还可以用于将小块血栓栓塞材料带入导管14。例如,分离器元件64可以通过血栓栓塞材料,平移某些材料并因而随着其向远端移动而在材料内形成通道。一旦分离器元件进一步定位到血栓栓塞内或者血栓栓塞的远端,某些平移的材料可能流回到该通道内。分离器元件64经材料(例如,经重新填充的通道)的后续收回将某些材料吸入到导管14内。为了促进该程序,优选提供分离器元件64和导管14使得导管腔36的直径与分离器元件64的最大直径之间的公差相当紧密。例如,在示范性实施例,分离器元件64的外径与管腔36的直径相差大约0.003-0.008英寸。Selective advancement of the
接下来描述一种备选方法,其中优选彼此独立地使用接收器和剥离器,虽然也可以如结合第一示范性方法所描述地组合使用。本方法描述为使用血栓栓塞接收器146和分离器16a执行,然而应该知道在所描述的方法中可以备选使用这些元件的其他实施例。An alternative method is described next, in which the receiver and stripper are preferably used independently of each other, although they can also be used in combination as described in connection with the first exemplary method. The method is described as being performed using the
根据备选方法。进行关于首先采用接收器146还是分离器16a的初始确定。这些确定可以随机进行,尽管在优选方法中,医生基于要去除的血栓栓塞材料的可能性质的确定选择适当的工具。具体来说,医生将评定患者以确定材料可能是硬的还是软/凝胶状的。这种评定可以包括评估例如当与血栓栓塞接触时导引线或分离器的尖部的响应、血栓栓塞材料位置、患者症状和/或由血栓栓塞引起的中风表明其自身的方式中的一种或多种因素。According to the alternative method. An initial determination is made as to whether to employ
如结合第一示范性方法所讨论的,导引及阻塞导管12引入到患者的脉管系统,并且对阻塞气囊28进行充气以便抑制血管内的血流(例如参见图14-图16)。As discussed in connection with the first exemplary method, the guide and
输送及吸取导管14通过导引及阻塞导管12并且定位成使其远端部处于接近血栓栓塞100的位置。如果医生选择在使用接收器146之前使用分离器16a,或者如果评估结果确定了血栓栓塞材料可能是有些软或者凝胶状的,激活吸取泵18以便在输送及吸取导管14内建立负压力,并因而将负压力施加到血栓栓塞100以便将血栓材料吸入导管14。The delivery and
如图24所示,分离器16a从输送及吸取导管14的远端部展开并且移动成与血栓栓塞材料100接触。如果需要,可以将分离器推进和收回多次。当如图所示地推进和收回时,分离器可以以一种或多种方式促进将血栓栓塞材料吸取到导管14内。首先,与血栓栓塞接触的分离器的移动可以松动、分离或者软化血栓栓塞材料片,以使血栓栓塞片可以吸取到导管内。第二,推进和收回分离器16a用于去除由于血栓栓塞材料经管腔36通过引起的输送及吸取导管14的管腔36内的阻塞或者流动限制。此外,在剥离器16a的收回过程中,其近端表面35将松动的材料推向或者插向和/或推入或者插入导管14的远端部以便后续吸取出体外。As shown in FIG. 24 ,
如果刚才描述的剥离器16a的使用表明血管包括在不进一步介入的情况下不能吸取的血栓栓塞材料硬块,优选将剥离器16a从导管14抽出并且将血栓栓塞接收器146通过输送及吸取导管14并在血管内展开。如果系统设置多个尺寸的接收器,医生选择对于正治疗的血管具有适当尺寸的接收器。If use of the
参见图25-图28,一旦接收器146展开,其膨胀成与周围的血管壁接触。随着接收器146朝主体血栓栓塞材料200推进,接收器146的壁在主体200周围滑动以便啮合和/或包围(部分或全部)血栓栓塞。啮合元件170啮合血栓栓塞200,由此将其保持在接收器内。如果需要,可以如图27的箭头所指示的,在远端方向上略微推进输送及吸取导管14,以便彼此朝向地“紧握”支柱构件162,因而使接收器146在径向向内的方向上略微收缩。此外,可以激活吸取泵18(图1)以便于将血栓栓塞200保持在接收器。输送及吸取导管14、接收器146以及血栓栓塞100抽回到导引及阻塞导管12并从身体抽回。如果其他血栓栓塞材料剩余在血管中,可以将新的输送及吸取导管14通入血管内,并将新的接收器经导管14展开以便收回其他血栓栓塞材料主体。25-28, once the
自然地,医生可以选择初始展开接收器,而不是分离器,例如如果初始评定结果确定血栓栓塞材料可能是硬的。随后如前面段落所描述的使用接收器146执行该方法。如果后续确定在血管中存在残留血栓栓塞材料(例如,软的或凝胶状材料),优选从身体取出接收器146,并将分离器16a通过输送及吸取导管14。激活吸取泵18并操纵分离器16a以便以上述方式促进软材料的吸取。Naturally, the physician may choose to initially deploy the receiver rather than the separator, for example if the initial assessment determines that the thromboembolic material may be hard. The method is then performed using the
尽管本发明容易受到各种修改和备选形式的影响,但是已经在附图中以实例形式显示了特定实施例并在本申请中进行了详细描述。然而,应该理解特定实施例的描述并不倾向于将本发明局限于所公开的特殊形式,而恰恰相反,本发明覆盖落入本发明的精神和范围内的所有修改、等同物以及备选方案。While the invention is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and described in detail in this application. It should be understood, however, that the description of specific embodiments is not intended to limit the invention to the particular forms disclosed, but on the contrary, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention .
Claims (90)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60902804P | 2004-09-10 | 2004-09-10 | |
| US60/609,028 | 2004-09-10 | ||
| US60/669,779 | 2005-04-08 | ||
| US60/680,605 | 2005-05-13 | ||
| US11/210,635 | 2005-08-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101027004A true CN101027004A (en) | 2007-08-29 |
| CN100591294C CN100591294C (en) | 2010-02-24 |
Family
ID=38744729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200580029886A Expired - Lifetime CN100591294C (en) | 2004-09-10 | 2005-08-25 | Systems and methods for treating ischemic stroke |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100591294C (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396295B (en) * | 2007-09-29 | 2010-11-03 | 成正辉 | Blood thrombus and embolus resectoscope |
| CN102319097A (en) * | 2011-08-04 | 2012-01-18 | 东莞永胜医疗制品有限公司 | Thrombus aspiration catheter and method of use thereof |
| CN102335022A (en) * | 2010-07-27 | 2012-02-01 | 上海理工大学 | Locally-plugged thrombus scaler |
| CN103417258A (en) * | 2012-05-14 | 2013-12-04 | 上海微创医疗器械(集团)有限公司 | Intracranial vascular thrombus removal equipment |
| CN103417257A (en) * | 2012-05-14 | 2013-12-04 | 上海微创医疗器械(集团)有限公司 | Intracranial vascular thrombus removal equipment |
| CN104000635A (en) * | 2013-02-21 | 2014-08-27 | 微创神通医疗科技(上海)有限公司 | Clot retriever and clot retrieval device |
| CN104053410A (en) * | 2011-10-05 | 2014-09-17 | 半影公司 | Systems and methods for treating ischemic stroke |
| CN104068909A (en) * | 2013-03-26 | 2014-10-01 | 上海微创医疗器械(集团)有限公司 | Intracranial vascular thrombus retrieval machine and thrombus retrieval device |
| CN105726088A (en) * | 2016-04-27 | 2016-07-06 | 湖南瑞康通科技发展有限公司 | Thrombus removing device |
| CN105919649A (en) * | 2016-06-15 | 2016-09-07 | 汕头大学医学院第附属医院 | Telescopic intravascular foreign body extraction device |
| US10531883B1 (en) | 2018-07-20 | 2020-01-14 | Syntheon 2.0, LLC | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| CN112702961A (en) * | 2018-09-10 | 2021-04-23 | 斯瑞克公司 | Laser grooving and grabbing device |
| CN113180914A (en) * | 2021-04-28 | 2021-07-30 | 河南科技大学第一附属医院 | Cerumen embolism softening and removing device |
| WO2021218793A1 (en) * | 2020-04-27 | 2021-11-04 | 先健科技(深圳)有限公司 | Thrombus removal apparatus |
| US12471937B2 (en) | 2023-01-25 | 2025-11-18 | Syntheon Pv, Llc | Aspiration thrombectomy systems and methods for thrombus removal with aspiration catheter |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6156055A (en) * | 1999-03-23 | 2000-12-05 | Nitinol Medical Technologies Inc. | Gripping device for implanting, repositioning or extracting an object within a body vessel |
| US6824545B2 (en) * | 2000-06-29 | 2004-11-30 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
| US20030040762A1 (en) * | 2001-08-22 | 2003-02-27 | Gerald Dorros | Apparatus and methods for treating stroke and controlling cerebral flow characteristics |
-
2005
- 2005-08-25 CN CN200580029886A patent/CN100591294C/en not_active Expired - Lifetime
Cited By (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396295B (en) * | 2007-09-29 | 2010-11-03 | 成正辉 | Blood thrombus and embolus resectoscope |
| CN102335022A (en) * | 2010-07-27 | 2012-02-01 | 上海理工大学 | Locally-plugged thrombus scaler |
| CN102335022B (en) * | 2010-07-27 | 2013-01-09 | 上海理工大学 | Locally-plugged thrombus scaler |
| CN102319097A (en) * | 2011-08-04 | 2012-01-18 | 东莞永胜医疗制品有限公司 | Thrombus aspiration catheter and method of use thereof |
| CN104053410B (en) * | 2011-10-05 | 2017-03-29 | 半影公司 | Systems and methods for treating ischemic stroke |
| CN104053410A (en) * | 2011-10-05 | 2014-09-17 | 半影公司 | Systems and methods for treating ischemic stroke |
| CN103417258B (en) * | 2012-05-14 | 2015-11-25 | 上海微创医疗器械(集团)有限公司 | Intracranial vessel gets pin device |
| CN103417258A (en) * | 2012-05-14 | 2013-12-04 | 上海微创医疗器械(集团)有限公司 | Intracranial vascular thrombus removal equipment |
| CN103417257A (en) * | 2012-05-14 | 2013-12-04 | 上海微创医疗器械(集团)有限公司 | Intracranial vascular thrombus removal equipment |
| CN103417257B (en) * | 2012-05-14 | 2016-03-30 | 微创神通医疗科技(上海)有限公司 | Intracranial vessel gets pin device |
| CN104000635A (en) * | 2013-02-21 | 2014-08-27 | 微创神通医疗科技(上海)有限公司 | Clot retriever and clot retrieval device |
| WO2014127738A1 (en) * | 2013-02-21 | 2014-08-28 | 微创神通医疗科技(上海)有限公司 | Thrombectomy device and thrombectomy equipment |
| CN104068909A (en) * | 2013-03-26 | 2014-10-01 | 上海微创医疗器械(集团)有限公司 | Intracranial vascular thrombus retrieval machine and thrombus retrieval device |
| CN105726088A (en) * | 2016-04-27 | 2016-07-06 | 湖南瑞康通科技发展有限公司 | Thrombus removing device |
| CN105919649A (en) * | 2016-06-15 | 2016-09-07 | 汕头大学医学院第附属医院 | Telescopic intravascular foreign body extraction device |
| US10722253B2 (en) | 2018-07-20 | 2020-07-28 | Syntheon 2.0, LLC | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12059161B2 (en) | 2018-07-20 | 2024-08-13 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12471938B2 (en) | 2018-07-20 | 2025-11-18 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12471936B2 (en) | 2018-07-20 | 2025-11-18 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12465380B2 (en) | 2018-07-20 | 2025-11-11 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US11406402B2 (en) | 2018-07-20 | 2022-08-09 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US11547426B2 (en) | 2018-07-20 | 2023-01-10 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US11918240B2 (en) | 2018-07-20 | 2024-03-05 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12004757B2 (en) | 2018-07-20 | 2024-06-11 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US10531883B1 (en) | 2018-07-20 | 2020-01-14 | Syntheon 2.0, LLC | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12082830B2 (en) | 2018-07-20 | 2024-09-10 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12185959B2 (en) | 2018-07-20 | 2025-01-07 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12433617B2 (en) | 2018-07-20 | 2025-10-07 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| US12446903B2 (en) | 2018-07-20 | 2025-10-21 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
| CN112702961A (en) * | 2018-09-10 | 2021-04-23 | 斯瑞克公司 | Laser grooving and grabbing device |
| WO2021218793A1 (en) * | 2020-04-27 | 2021-11-04 | 先健科技(深圳)有限公司 | Thrombus removal apparatus |
| CN113180914A (en) * | 2021-04-28 | 2021-07-30 | 河南科技大学第一附属医院 | Cerumen embolism softening and removing device |
| US12471937B2 (en) | 2023-01-25 | 2025-11-18 | Syntheon Pv, Llc | Aspiration thrombectomy systems and methods for thrombus removal with aspiration catheter |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100591294C (en) | 2010-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7931659B2 (en) | System and method for treating ischemic stroke | |
| US12096951B2 (en) | System and method for treating ischemic stroke | |
| EP1799128B1 (en) | System for treating ischemic stroke | |
| US10993731B2 (en) | System and method for treating ischemic stroke | |
| US11857210B2 (en) | Clot retrieval device for removing clot from a blood vessel | |
| EP1684647B1 (en) | Unfolding balloon catheter for proximal embolus protection | |
| CN100591294C (en) | Systems and methods for treating ischemic stroke | |
| CA3008899A1 (en) | A clot retrieval device for removing occlusive clot from a blood vessel | |
| JP2014533131A5 (en) | ||
| EP3451953A1 (en) | Internal carotid artery thrombectomy devices and methods | |
| EP1427460A4 (en) | CATHETER WITH RADIAL EXPANDABLE MAIN BODY | |
| WO2021055148A1 (en) | Devices for removing obstructing materials from blood vessels | |
| AU2002341546A1 (en) | Catheter having radially expandable main body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20100224 |